Immunogenicity and Safety of One Dose of HPV Vaccine

Clinical trial NCT06345885 · COMPLETED

Trial details

NCT number: NCT06345885
Sponsor: Xiamen Innovax Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Papillomavirus Vaccines

Start date: 2023-02-23
Primary completion: 2024-01-17
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.